Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7

Insulet (Nasdaq: PODD)+ today announced a new integration for its Omnipod 5 platform, building on its partnership with Dexcom (Nasdaq: DXCM)

Our sister site, Drug Delivery Business News, reports today that Insulet announced the compatibility of its Omnipod 5 App for iPhone with Dexcom G7 continuous glucose monitor (CGM). The latest integration combines the benefits of the companies’ latest technologies, all conveniently controlled from an iPhone.

Insulet’s Omnipod 5 App for iPhone offers full control of Omnipod 5, including the ability to bolus, change a pod, adjust settings, access insights and more. Users can now download the new app with Dexcom G7 and G6 compatibility from the Apple App Store.

Sign up for Blog Updates